Riccardo Braglia

RICCARDO BRAGLIA An entrepreneur and manager with over 40 years of international experience in pharmaceuticals and scientific investments, he has led Helsinn Healthcare, a family-owned group specializing in oncology support therapies and cancer treatments, with offices in Switzerland, the EU, the US, and China, as President and CEO since 2002. He is Vice President of 3B Future Holding and President of HAS Healthcare Advanced Synthesis and Cerbios-Pharma. He actively supports philanthropic projects focused on cancer research, healthcare, and education in Africa and is a co-founder of the Nuovo Fiore in Africa Foundation.